Your browser doesn't support javascript.
loading
Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease.
Plank, Anne-Christine; Canneva, Fabio; Raber, Kerstin A; Urbach, Yvonne K; Dobner, Julia; Puchades, Maja; Bjaalie, Jan G; Gillmann, Clarissa; Bäuerle, Tobias; Riess, Olaf; Nguyen, Hoa H P; von Hörsten, Stephan.
Afiliação
  • Plank AC; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
  • Canneva F; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
  • Raber KA; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
  • Urbach YK; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
  • Dobner J; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
  • Puchades M; Neural Systems Laboratory, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Bjaalie JG; Neural Systems Laboratory, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Gillmann C; Preclinical Imaging Platform Erlangen, Institute of Radiology, University Clinics Erlangen, Erlangen, Germany.
  • Bäuerle T; Preclinical Imaging Platform Erlangen, Institute of Radiology, University Clinics Erlangen, Erlangen, Germany.
  • Riess O; Institute of Medical Genetics and Applied Genomics, University Clinics Tuebingen, Tuebingen, Germany.
  • Nguyen HHP; Institute of Medical Genetics and Applied Genomics, University Clinics Tuebingen, Tuebingen, Germany.
  • von Hörsten S; Experimental Therapy, Preclinical Experimental Center, University Clinics Erlangen, Erlangen, Germany.
Front Neurosci ; 12: 11, 2018.
Article em En | MEDLINE | ID: mdl-29422836
ABSTRACT
The transgenic rat model of Huntington disease expressing a fragment of mutant HTT (tgHD rat) has been thoroughly characterized and reproduces hallmark symptoms of human adult-onset HD. Pursuing the optimization of this model for evaluation of translational therapeutic approaches, the F344 inbred rat strain was considered as advantageous genetic background for the expression of the HD transgenic construct. In the present study, a novel congenic line of the SPRDtgHD transgenic model of HD, carrying 51 CAG repeats, was generated on the F344 rat genetic background. To assess the behavioral phenotype, classical assays investigating motor function, emotion, and sensorimotor gating were applied, along with automated screening of metabolic and activity parameters as well as operant conditioning tasks. The neuropathological phenotype was analyzed by immunohistochemistry and ex vivo magnetic resonance imaging. F344tgHD rats displayed markedly reduced anxiety-like behavior in the social interaction test and elevated impulsivity traits already at 3 months of age. Neuropathologically, reduced striatal volume and pronounced aggregation of mutant huntingtin in several brain regions were detected at later disease stage. In conclusion, the congenic F344tgHD model reproduces key aspects of the human HD phenotype, substantiating its value for translational therapeutic approaches.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha